Glenmark Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE935A01035
  • NSEID: GLENMARK
  • BSEID: 532296
INR
1,960.90
45.75 (2.39%)
BSENSE

Feb 03

BSE+NSE Vol: 5.46 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryGlenmark Pharma VS Pharmaceuticals & Biotechnology
 
1D
2.39%
2.54%
1W
-2.01%
2.3%
1M
-5.32%
-2.36%
YTD
-3.68%
-1.74%
1Y
39.14%
8.49%
3Y
408.27%
37.63%
5Y
291.08%
66.63%
10Y
163.35%
245.7%
  • Stock Absolute Returns
  • Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.26%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
3.31%
0%
3.31%
6 Months
-5.13%
0.25%
-4.88%
1 Year
39.14%
0.33%
39.47%
2 Years
121.27%
0.93%
122.2%
3 Years
408.27%
2.31%
410.58%
4 Years
295.42%
2.76%
298.18%
5 Years
291.08%
3.15%
294.23%

Latest dividend: 2.5 per share ex-dividend date: Oct-03-2025

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Industry stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Market Cap stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
stock-summaryRisk Adjusted Returns v/s
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available